Agenus reported $15.2M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US $ 15.2M 1.37M
Amgen AMGN:US $ 328M 33M
Bristol Myers Squibb BMY:US $ 313M 13M
Chemocentryx CCXI:US $ 0.6M 0.05M
CSL CSL:AU $ 67.8M 11.3M
Dynavax Technologies DVAX:US $ 1.68M 0M
Eli Lilly And LLY:US $ 81.2M 3.7M
Gilead Sciences GILD:US $ 242M 4M
Immunogen IMGN:US $ 1.08M 0.17M
Karyopharm Therapeutics KPTI:US $ 6.31M 371K
Northwest Biotherapeutics NWBO:US 1.9M 750K
Novartis NOVN:VX 202M 1000K
Pfizer PFE:US $ 293M 29M
Regeneron Pharmaceuticals REGN:US $ 13.1M 0.5M
Veracyte VCYT:US $ 0.07M 0.01M
YTE INCY:US $ 0.68M 0M